Natalia V. Skripchenko

Natalia V. Skripchenko

Auto-generated profile, based on publicly available information

Natalia V. Skripchenko

Pediatric Research and Clinical Center for Infectious Diseases; Saint Petersburg State Pediatric Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2020 in Kuban Scientific Medical Bulletin
Verified
Journal Article
Open access
PDF file
YLYu. V. Lobzin
Yu. V. Lobzin
SRS. V. Rychkova
S. V. Rychkova
AUA. N. Uskov
A. N. Uskov
NSN. V. Skripchenko
N. V. Skripchenko
VFV. V. Fedorov
V. V. Fedorov
The onset of 2020 clearly demonstrated that infection agents pose a major threat to mankind. Current infectiology is shaped by resurrection of “old” seemingly forgotten infections, emergence of “new” infection agents, unusual combinations of known agents, evolving resistance of microorganisms to antibacterial drugs, transformation of human microbiome leading to distortions in herd immunity and, ultimately, emergence of healthcare-related infectious diseases, not letting alone threats of bioterror. Infection agents evolve together with mankind. Novel facets emerge in infectiology, alongside with trends in diagnosis, treatment and prevention of infectious diseases that become more diverse as the list of pathogens grows. Human and infection agent links extend beyond antagonistic relations towards symbiosis. Microorganisms adapt quickly in the new technogenic environment giving rise to novel pathogens and making it unlikely for the mankind to get free from infections any time soon.The total economic damage from infectious diseases increases by year, despite continuous improvement in therapy. Infectious mortality in children aged 0 to 14 years is the top fourth among other causes of death. The work assesses comparative dynamics of “common” childhood infections in the Russian Federation during 2018–2020. We analyse official statistics on paediatric infectious morbidity, comparative dynamics of main infectious diseases (acute respiratory diseases, intestinal infections of bacterial and viral nature, neuroinfections, anthropozoonotic infections, viral hepatitises), assess trends in morbidity of vaccine-preventable infections in children and adults in the Russian Federation, with greater detail towards selected regions, from January 2018 to April 2020.

14 July 2022 in Russian neurological Journal
Verified
Journal Article
Closed access
PDF file
ILI. V. Litvinenko
I. V. Litvinenko
VLV. Yu. Lobzin
V. Yu. Lobzin
VPV. A. Pushkarev
V. A. Pushkarev
NSN. V. Skripchenko
N. V. Skripchenko
Since the description of the first clinical cases of the most common neurodegenerative diseases, numerous hypotheses have been proposed for their development. At the same time, the failure of therapeutic strategies in various directions of clinical research indicates the fallacy of most theories. In this regard, in recent years, various infectious agents are increasingly considered as a trigger of neuronal inflammation and a factor inducing the onset of the neurodegenerative process. Infectious agents differ in their mechanisms of invasion into the central nervous system and can even enter the brain perineurally. Reactivation of latent viral infection induces the production of viral proteins and the accumulation of abnormal proteins that are markers of Alzheimer’s disease and Parkinson’s disease. Both bacterial (chlamydia, causative agents of chronic periodontitis, E. coli) and viral (herpes viruses, noroviruses) infectious agents are considered. However, for the development of neurodegeneration, it is not enough just a simple invasion and reactivation of the infectious process: the genetic characteristics of the main histocompatibility complex also play a huge role. Currently, several studies have been initiated on the possible efficacy of antibacterial and antiviral drugs in Alzheimer’s disease. Data obtained over the past year suggests that the brain may act as a target for SARS-CoV-2. Neurological manifestations of COVID-19 can occur as a result of both the direct cytopathic action of the pathogen and the activation of neuroinflammation, accompanied by a violation of the integrity of the blood-brain barrier. Further study of the molecular and cellular mechanisms of neuroinflammation and neurodegeneration in COVID-19 will form the basis for the development of treatments for neurological complications.

1 April 2023 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
NGN. V. Gonchar
N. V. Gonchar
AKA. K. Kopersak
A. K. Kopersak
NSN. V. Skripchenko
N. V. Skripchenko
AKA. S. Kvetnaya
A. S. Kvetnaya
AMA. M. Moskalyuk
A. M. Moskalyuk
SGS. G. Grigor'EV
S. G. Grigor'EV
Резистентность к антибактериальным препаратам и бактериофагам изолятов Klebsiella pneumoniae , выделенных от детей разного возраста с кишечными инфекциями

14 December 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
KEKonstantin Ermolenko
Konstantin Ermolenko
NGN.V. Gonchar
N.V. Gonchar
NSN.V. Skripchenko
N.V. Skripchenko
Objective of the research: to analyze clinical and laboratory manifestations of COVID-19 with a predominant lesion of the gastrointestinal tract (GIT) in children. It was revealed that incidence of this form of COVID-19 in children is underestimated. Based on the analysis of literature data and original clinical observations, the article describes current ideas about the frequency of detecting the form of COVID-19 with a predominant lesion of the GIT, its clinical and laboratory characteristics, the mechanisms of infectious process development in the digestive organs and approaches to rational laboratory diagnostics. The feasibility of PCR in feces in patients with suspected COVID-19 is confirmed. A description of a clinical case of COVID-19 severe form, which required differential diagnosis with acute bacterial gastroenterocolitis, is presented.

30 June 2019 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
ESE. Yu. Skripchenko
E. Yu. Skripchenko
GZG. F. Zheleznikova
G. F. Zheleznikova
NSN. V. Skripchenko
N. V. Skripchenko
LAL. A. Alekseeva
L. A. Alekseeva
ASA. V. Surovtseva
A. V. Surovtseva
The review focuses on autoimmune encephalitis with antibodies to NMDA receptors, previously unknown autoimmune disease of the central nervous system, described in 2007. Anti-NMDAR encephalitis develops in adults and children, due to the tumor process and without it, it is manifested by characteristic syndrome of neurological and mental disorders. The authors separate anti-NMDAR encephalitis, which develops after the resolution of encephalitis caused by the herpes simplex virus-1. They describe the clinical manifestations of anti-NMDAR encephalitis in children and the effectiveness of early immunotherapy. Perspectively they discuss the pathogenesis of the disease, as well as the connection of herpes simplex virus infection and the development of anti-NMDAR encephalitis.

11 February 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
IFI.V. Friedman
I.V. Friedman
SKS.M. Kharit
S.M. Kharit
NSN.V. Skripchenko
N.V. Skripchenko
OYO.V. Yozefovich
O.V. Yozefovich
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.